Neurogene Inc (NGNE) — Capital Reinvestment Ratio

Latest as of June 2018: 0.00x

Neurogene Inc (NGNE) has a Capital Reinvestment Ratio of 0.00x as of June 2018, meaning it reinvests 0% of its operating cash flow ($9.25 Million) in capital expenditures ($28.31K). Check how tangible is Neurogene Inc's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$9.25 Million

USD

Capital Expenditures

$28.31K

USD

Data as of

Jun 2018

Most recent filing

Annual Capital Reinvestment Ratio for Neurogene Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Neurogene Inc from None to None. See Neurogene Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow